Andreea Ciudin1, Olga Simó-Servat2, Jose Maria Balibrea3, Ramon Vilallonga3, Cristina Hernandez2, Rafael Simó2, Jordi Mesa2. 1. Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Spain; Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: aciudin@vhebron.net. 2. Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Spain; Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain. 3. Bariatric Surgery Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Abstract
BACKGROUND: Chronic intravenous iron administration is often required after bariatric surgery. Oral sucrosomial iron has a particular form of absorption and may represent an alternative treatment. OBJECTIVE: To assess the effect of switching to oral sucrosomial iron in patients receiving intravenous iron supplementation after bariatric surgery. PATIENTS AND METHODS: A case-control study was conducted on 40 women of childbearing age, of whom 20 were switched to oral sucrosomial iron, while 20 patients continued on intravenous iron sucrose every three months. RESULTS: No significant differences were seen in Hb, ferritin, and TSI levels before and after three months of treatment with sucrosomial iron. CONCLUSION: Oral sucrosomial iron could be an alternative in patients who require parenteral treatment with iron after bariatric surgery.
BACKGROUND: Chronic intravenous iron administration is often required after bariatric surgery. Oral sucrosomial iron has a particular form of absorption and may represent an alternative treatment. OBJECTIVE: To assess the effect of switching to oral sucrosomial iron in patients receiving intravenous iron supplementation after bariatric surgery. PATIENTS AND METHODS: A case-control study was conducted on 40 women of childbearing age, of whom 20 were switched to oral sucrosomial iron, while 20 patients continued on intravenous iron sucrose every three months. RESULTS: No significant differences were seen in Hb, ferritin, and TSI levels before and after three months of treatment with sucrosomial iron. CONCLUSION: Oral sucrosomial iron could be an alternative in patients who require parenteral treatment with iron after bariatric surgery.
Authors: Elizabeth Katherine Batchelor; Pinelopi Kapitsinou; Pablo E Pergola; Csaba P Kovesdy; Diana I Jalal Journal: J Am Soc Nephrol Date: 2020-02-10 Impact factor: 10.121
Authors: Guillermo Bastida; Claudia Herrera-de Guise; Alicia Algaba; Yolanda Ber Nieto; Jose Manuel Soares; Virginia Robles; Fernando Bermejo; Esteban Sáez-González; Fernando Gomollón; Pilar Nos Journal: Nutrients Date: 2021-05-22 Impact factor: 5.717